Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 3
1988 4
1989 6
1990 5
1991 1
1992 6
1993 3
1994 6
1995 3
1996 2
1997 5
1998 5
1999 7
2000 2
2001 3
2002 3
2003 1
2004 5
2005 3
2006 4
2007 2
2008 12
2009 11
2010 12
2011 18
2012 16
2013 15
2014 11
2015 29
2016 23
2017 26
2018 15
2019 16
2020 20
2021 20
2022 16
2023 16
2024 9
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
Antifungal Drugs TDM: Trends and Update.
Kably B, Launay M, Derobertmasure A, Lefeuvre S, Dannaoui E, Billaud EM. Kably B, et al. Among authors: billaud em. Ther Drug Monit. 2022 Feb 1;44(1):166-197. doi: 10.1097/FTD.0000000000000952. Ther Drug Monit. 2022. PMID: 34923544 Review.
[Phaeochromocytoma and paraganglioma].
Cornu E, Belmihoub I, Burnichon N, Grataloup C, Zinzindohoué F, Baron S, Billaud E, Azizi M, Gimenez-Roqueplo AP, Amar L. Cornu E, et al. Among authors: billaud e. Rev Med Interne. 2019 Nov;40(11):733-741. doi: 10.1016/j.revmed.2019.07.008. Epub 2019 Sep 4. Rev Med Interne. 2019. PMID: 31493938 Review. French.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
A highly virulent variant of HIV-1 circulating in the Netherlands.
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Niveau de preuve du suivi thérapeutique pharmacologique du posaconazole.
Lefeuvre S, Jelassi ML, Benlmouden A, Berge M, Le Guellec C, Billaud EM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Lefeuvre S, et al. Among authors: billaud em. Therapie. 2011 Mar-Apr;66(2):115-22. doi: 10.2515/therapie/2011010. Therapie. 2011. PMID: 27393646 French.
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.
Degasperi E, Anolli MP, Jachs M, Reiberger T, De Ledinghen V, Metivier S, D'Offizi G, di Maria F, Schramm C, Schmidt H, Zöllner C, Tacke F, Dietz-Fricke C, Wedemeyer H, Papatheodoridi M, Papatheodoridis G, Carey I, Agarwal K, Van Bömmel F, Brunetto MR, Cardoso M, Verucchi G, Ciancio A, Zoulim F, Aleman S, Semmo N, Mangia A, Hilleret MN, Merle U, Santantonio TA, Coppola N, Pellicelli A, Roche B, Causse X, D'Alteroche L, Dumortier J, Ganne N, Heluwaert F, Ollivier I, Roulot D, Viganò M, Loglio A, Federico A, Pileri F, Maracci M, Tonnini M, Arpurt JP, Barange K, Billaud E, Pol S, Gervais A, Minello A, Rosa I, Puoti M, Lampertico P. Degasperi E, et al. Among authors: billaud e. J Hepatol. 2025 Jun;82(6):1012-1022. doi: 10.1016/j.jhep.2024.12.044. Epub 2025 Jan 8. J Hepatol. 2025. PMID: 39793613
Current evidence gaps to support systematic cytomegalovirus screening in pregnancy.
Billette de Villemeur A, Hoen B, Billaud E, Deruelle P, Goueslard K, Halley des Fontaines V, Minodier P, Parent B, Pozzetto B, Revest M, Salmi LR. Billette de Villemeur A, et al. Among authors: billaud e. EClinicalMedicine. 2024 Nov 22;78:102941. doi: 10.1016/j.eclinm.2024.102941. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39640941 Free PMC article. Review.
Niveau de preuve pour le suivi thérapeutique pharmacologique de la vancomycine.
Jelassi ML, Benlmouden A, Lefeuvre S, Mainardi JL, Billaud EM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie de Thérapeutique. Jelassi ML, et al. Among authors: billaud em. Therapie. 2011 Jan-Feb;66(1):29-37. doi: 10.2515/therapie/2011005. Therapie. 2011. PMID: 27393462 French.
330 results